---
document_datetime: 2023-09-21 20:26:25
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/odomzo-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: odomzo-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.7792673
conversion_datetime: 2025-12-30 20:54:45.240725
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Odomzo

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0037              | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                 | 07/04/2021                          |                                             | SmPC and PL                      |           |
| II/0035              | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority | 25/02/2021                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| PSUSA/10408 /202006   | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                                          | 14/01/2021   | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                    |
|-----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0034               | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 30/10/2020   | n/a        |                                  |                                                                                                                                                                                                                                                                      |
| N/0032                | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                 | 30/09/2020   |            | PL                               |                                                                                                                                                                                                                                                                      |
| IB/0031               | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                           | 17/07/2020   | n/a        |                                  |                                                                                                                                                                                                                                                                      |
| PSUSA/10408 /201912   | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                                          | 09/07/2020   | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                    |
| R/0028                | Renewal of the marketing authorisation.                                                                                                                                                          | 26/03/2020   | 20/05/2020 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Odomzo in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| II/0024               | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                    | 12/03/2020   | n/a        |                                  |                                                                                                                                                                                                                                                                      |
| PSUSA/10408 /201906   | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                                          | 16/01/2020   | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

| IA/0027/G           | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites   | 11/10/2019   | n/a        |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------------------|
| N/0025              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                 | 08/08/2019   | 04/10/2019 |                                   |
| PSUSA/10408 /201812 | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                          | 11/07/2019   | n/a        | PRAC Recommendation - maintenance |
| PSUSA/10408 /201806 | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                          | 17/01/2019   | n/a        | PRAC Recommendation - maintenance |
| IB/0021             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                        | 02/10/2018   | 04/10/2019 | SmPC and PL                       |
| IB/0020             | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data           | 08/08/2018   | n/a        |                                   |
| PSUSA/10408 /201712 | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                          | 12/07/2018   | n/a        | PRAC Recommendation - maintenance |
| II/0016             | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing                                                                                       | 25/01/2018   | 08/05/2018 | Annex II                          |

<div style=\"page-break-after: always\"></div>

|                     | authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |                        |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| PSUSA/10408 /201706 | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 11/01/2018 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0017             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 15/12/2017 | 08/05/2018 | SmPC, Labelling and PL |                                   |
| IAIN/0018/G         | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - | 14/12/2017 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|                     | responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |            |            |             |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------|
| II/0011             | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 06/07/2017 | 08/05/2018 | SmPC and PL |                                   |
| PSUSA/10408 /201612 | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 06/07/2017 | n/a        |             | PRAC Recommendation - maintenance |
| IB/0014/G           | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data | 04/07/2017 | n/a        |             |                                   |
| IB/0013             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 06/06/2017 | n/a        |             |                                   |
| II/0010             | C.I.4 - Change(s) in the SPC, Labelling or PL due to                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 01/06/2017 | 08/05/2018 | SmPC and PL |                                   |

<div style=\"page-break-after: always\"></div>

|                     | new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |                        |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| T/0012              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 31/03/2017 | 31/05/2017 | SmPC, Labelling and PL |                                   |
| II/0008/G           | This was an application for a group of variations. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation | 26/01/2017 | 31/05/2017 | SmPC                   |                                   |
| II/0007             | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                                                                | 26/01/2017 | n/a        |                        |                                   |
| PSUSA/10408 /201606 | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                                                                                                                                                                                                                                                                                                                                      | 12/01/2017 | n/a        |                        | PRAC Recommendation - maintenance |
| II/0005             | To resolve two post-authorisation measures (Post Authorisation Efficacy Studies) listed in the Annex II.D of the Marketing Authorisation, resulting in an update of the sections 4.8 and 5.1 of the SmPC, the Annex II and RMP.                                                                                                                                                                                                                                                              | 10/11/2016 | 31/05/2017 | SmPC and Annex II      |                                   |

<div style=\"page-break-after: always\"></div>

|                     | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10408 /201512 | Periodic Safety Update EU Single assessment - sonidegib                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 07/07/2016 | n/a | PRAC Recommendation - maintenance |
| II/0004/G           | This was an application for a group of variations. Submission of the final Clinical Study Reports (CSRs) for studies X2114 and X2203, whereby the MAH committed to collect cardiac events, second primary malignancies and fractures. These two exploratory studies conclude that the safety profile for sonidegib remains unchanged. None of them led to an update of the product information. In addition, the MAH proposed updates to the EU Risk Management Plan (RMP, v3.2) to reflect completion of these studies (X2114 and X2203) and changes to the due dates for provision of the final study reports for the category 3 studies LDE225C2301 and LDE225X2104. The requested group of variations proposed amendments to the Risk Management Plan. C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation | 26/05/2016 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|           | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0002   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 18/03/2016 | n/a        |      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| II/0001/G | This was an application for a group of variations. Update of sections 4.2 and 5.2 of the SmPC to add information on posology and pharmacology of sonidegib in hepatic impaired patients based on results from study CLDE225A2113 (MEA 006) and update of section 4.5 of the SmPC to add information on Drug-Drug interaction with proton pump inhibitors (esomeprazole) based on results from study CLDE225A2118 (MEA 007). The Risk Management Plan of the product has been updated accordingly and the final version approved is 3.1. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 28/01/2016 | 24/02/2016 | SmPC | No dose adjustment is necessary in patients with mild (Child Pugh class A) or moderate (Child Pugh class B) hepatic impairment. Results from a clinical study demonstrated a change in sonidegib exposure (32% and 38% decrease in AUC and Cmax ) after co-administration of a single dose of Odomzo 200 mg with esomeprazole (a proton pump inhibitor) at 40 mg daily for 6 days in healthy subjects. This interaction is not expected to be clinically significant. |